Trials / Completed
CompletedNCT01782937
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
A Long-Term Study of KHK4827 in Subjects With Pustular Psoriasis (Generalized) and Psoriatic Erythroderma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, non-controlled study to evaluate the efficacy and safety of KHK4827 in subjects with pustular psoriasis (generalized) and psoriatic erythroderma. Pharmacokinetics of KHK4827 will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK4827 | 140 mg (dosage may be increased to 210 mg in case of insufficient efficacy) |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-02-04
- Last updated
- 2015-02-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01782937. Inclusion in this directory is not an endorsement.